Testing effectiveness (Phase 2)Ended earlyNCT01773889
What this trial is testing
A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer
Who this might be right for
Epithelial Ovarian CancerExtraovarian Peritoneal CancerFallopian Tube Carcinoma
The University of Texas Health Science Center at San Antonio 2